"10.1371_journal.pone.0035074","plos one","2012-04-06T00:00:00Z","Rafael Van den Bergh; Sébastien Morin; Hans Jürgen Sass; Stephan Grzesiek; Marc Vekemans; Eric Florence; Huyen Thanh Thi Tran; Rosina Gabriel Imiru; Leo Heyndrickx; Guido Vanham; Patrick De Baetselier; Geert Raes","Department of Molecular and Cellular Interactions, VIB, Brussels, Belgium; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; Division of Structural Biology, Biozentrum der Universität Basel, Basel, Switzerland; HIV/STD Unit, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Virology Unit, Department of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium; Department of Biomedical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, and Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium","Conceived and designed the experiments: RVdB GV PDB SG LH GR. Performed the experiments: RVdB HTTT RGI LH SM HJS. Analyzed the data: RVdB HTTT RGI SG HJS. Contributed reagents/materials/analysis tools: MV EF. Wrote the paper: RVdB. Consulted patients and provided biological samples and clinical data: MV EF.","A patent concerning the use of visfatin as an HIV-associated biomarker has been filed by RVdB, GV, PDB and GR (patent application number 20100184031, NOVEL ADIPOCYTOKINE VISFATIN/PBEF1 IS AN APOPTOSIS ASSOCIATED FACTOR INDUCED IN MONOCYTES DURING IN VIVO HIV-1 INFECTION). This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","04","Rafael Van den Bergh","RVDB",12,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
